We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » South Africa Implements Drug Naming Guidance, After Review
South Africa Implements Drug Naming Guidance, After Review
The proprietary name of a drug should include either the International Non-Proprietary Name or a description of its effects, and should be consistent across the product’s range, according to revised guidance from South Africa’s Medicines Control Council.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor